Related Experiment Video
Updated: Aug 19, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
Published on: September 6, 2024
Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin
William J Tanski1, Suzanne M Nicholl, Dong Kim
1Division of Vascular Surgery, Vascular Biology and Therapeutics Program, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Background:
Vascular smooth muscle cell (SMC) migration is an important component of the development of intimal hyperplasia. Sphingosine-1-phosphate (S-1-P) is a lipid released from activated platelets with numerous cellular effects including the stimulation of SMC migration in vitro. We examined the role of the mammalian target of rapamycin and ribosomal p70S6 kinase (p70S6K) in S-1-P-induced SMC migration .
Methods:
Rat arterial SMCs were cultured in vitro. Linear wound and Boyden microchemotaxis assays of migration were performed in the presence of S-1-P (0.01 to 100 micromol/L) with and without rapamycin (10 nmol/L). Western blotting was performed for phosphorylated and total p70S6K, ERK1/2, and p38(MAPK) after stimulation with S-1-P (0.1 micromol/L), with and without rapamycin pretreatment. Phosphorylation of p70S6K was also assayed after S-1-P treatment in the presence and absence of inhibitors of PI3 kinase (wortmannin, WN, and LY294002, LY), Akt (AktI), p38(MAPK) (SB203580), and MEK1 (PD98059).
Results:
S-1-P stimulated migration of SMCs in both linear wound and Boyden chamber assays compared to control (P < .05); these responses were inhibited by rapamycin to below the level of control (P < .05 vs S-1-P alone for both assays) in a dose-dependent manner (inhibitory concentration of 50%, 10 nmol/L). S-1-P stimulated phosphorylation of ERK1/2, p38(MAPK), and p70S6K, which peaked at 5 minutes for ERK1/2 and p38(MAPK) and10 minutes for p70S6K (2-fold increase over control for each, P < .05). Rapamycin prevented the phosphorylation of p70S6K at the Thr 389 site (which correlates with enzyme activity), reduced ERK1/2 phosphorylation, but had no effect on the Thr 421/Ser 424 site or on p38(MAPK) phosphorylation. Wortmannin and LY294002 inhibited phosphorylation of the Thr 389 site of p70S6K. AktI and SB203580 had no effect on p70S6K, whereas PD98059 had a marginal effect.
Conclusions:
S-1-P-induced SMC migration was completely inhibited by rapamycin, indicating that the p70S6K pathway is involved. This mechanism likely involves modulation of the ERK1/2 pathway. S-1-P stimulates phosphorylation of p70S6K in a MEK1-dependent, PI3 kinase-dependent, but Akt-independent manner.
Insights
Rapamycin completely inhibits sphingosine-1-phosphate (S-1-P)-induced vascular smooth muscle cell (SMC) migration by targeting the mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase (p70S6K) pathway. This pathway is crucial for intimal hyperplasia development.
Area of Science:
- Vascular Biology
- Cell Signaling
- Molecular Medicine
Background:
- Vascular smooth muscle cell (SMC) migration is a key process in intimal hyperplasia.
- Sphingosine-1-phosphate (S-1-P), released by platelets, stimulates SMC migration.
- The role of mammalian target of rapamycin (mTOR) and p70S6 kinase (p70S6K) in S-1-P-induced migration requires investigation.
Purpose of the Study:
- To investigate the involvement of the mTOR/p70S6K pathway in S-1-P-induced SMC migration.
- To elucidate the signaling mechanisms underlying S-1-P-mediated SMC migration.
Main Methods:
- Rat arterial SMCs were subjected to wound healing and Boyden chamber assays.
- Cellular responses to S-1-P were assessed with and without rapamycin treatment.
- Western blotting analyzed the phosphorylation status of p70S6K, ERK1/2, and p38(MAPK) under various conditions, including inhibition of PI3K, Akt, p38(MAPK), and MEK1.
Main Results:
- S-1-P significantly stimulated SMC migration, an effect completely abrogated by rapamycin.
- Rapamycin inhibited p70S6K phosphorylation at Thr 389 and reduced ERK1/2 phosphorylation.
- S-1-P-induced p70S6K phosphorylation was dependent on MEK1 and PI3K but independent of Akt.
Conclusions:
- The p70S6K pathway, modulated by mTOR, is essential for S-1-P-induced SMC migration.
- The ERK1/2 pathway is likely involved in this process.
- S-1-P regulates p70S6K phosphorylation via a MEK1- and PI3K-dependent, Akt-independent signaling cascade.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Cell Migration
Cytoskeletal Coordination in Cell Migration
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...
MAPK Signaling Cascades

